References
- Franz DR. Defense against toxin weapons. In: Sidell FR, Takafuji ET, Franz DR, eds. Medical aspects of chemical and biological warfare. Textbook of military medicine. Part 1. Warfare, weaponry, and the casualty. Vol 3. Washington, DC: Office of the Surgeon General, Dept of the Army, 1997: 603–19
- Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001;285(8): 1059–70
- Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278(5): 399–411
- Convention on the Prohibition of the Development, Production, and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction. April 1972. Appendix 1. Available at: http://www.state.gov/www/global/arms/treaties/bwcl.html. Accessed May 6, 2002
- Madsen JM. Toxins as weapons of mass destruction: a comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 2001;21(3): 593–605
- Centers for Disease Control and Prevention. Botulism in the United States, 1899–1996: handbook for epidemiologists, clinicians, and laboratory workers. Atlanta: US Dept of Health and Human Services, Public Health Service, 1998. Available at: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/botulism.pdf. Accessed May 3, 2002
- Ulrich RG, Sidell S, Taylor TJ, et al. Staphylococcal enterotoxin B and related pyrogenic toxins. In: Sidell et al, eds,1 pp 621–30
- Mollick JA, Cook RG, Rich RR. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science 1989;244(4906): 817–20
- Fraser JD. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 1989;339(6221): 221–3
- Ciegler A. Mycotoxins: occurrence, chemistry, biological activity. Lloydia 1975;38(1): 21–35
- Wannemacher RW, Wiener SL. Trichothecene mycotoxins. In: Sidell et al, eds,1 pp 655–76
- Zilinskas RA. Iraq's biological weapons. The past as future? JAMA 1997; 278(5): 418–24
- McGovern TW, Christopher GW, Eitzen EM. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol 1999; 135(3): 311–22
- Hsueh CC, Liu Y, Freund MS. Indirect electrochemical detection of type-B trichothecene mycotoxins. Anal Chem 1999;71(18): 4075–80
- Black RM, Clarke RJ, Read RW. Detection of trace levels of trichothecene mycotoxins in human urine by gas chromatography-mass spectrometry. J Chromatogr 1986;367(1): 103–15
- Lee RC, Wei RD, Chu FS. Enzyme-linked immunosorbent assay for T-2 toxin metabolites in urine. J Assoc Off Anal Chem 1989;72(2): 345–8
- Fricke RF, Jorge J. Assessment of efficacy of activated charcoal for treatment of acute T-2 toxin poisoning. J Toxicol Clin Toxicol 1990;28(4): 421–31
- Ryu JC, Shiraki N, Ueno Y. Effects of drugs and metabolic inhibitors on the acute toxicity of T-2 toxin in mice. Toxicon 1987;25(7): 743–50
- Shohami E, Wisotsky B, Kempski O, et al. Therapeutic effect of dexa-methasone in T-2 toxicosis. Pharm Res 1987;4(6): 527–30